Lydia Visser - Search Results

Year	Number of Results
2002	1
2004	2
2005	2
2006	3
2007	5
2008	4
2009	3
2010	5
2011	4
2012	6
2013	2
2014	5
2015	3
2016	6
2017	4
2018	9
2019	6
2020	6
2021	4
2022	6

1

Erratum: Lydia Visser et al. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma, Int. J. Mol. Sci. 2016, 17, 2127.

Sattarzadeh A, Visser L, Rutgers B, Diepstra A, van den Berg A. Sattarzadeh A, et al. Among authors: visser l. Int J Mol Sci. 2018 Jan 19;19(1):304. doi: 10.3390/ijms19010304. Int J Mol Sci. 2018. PMID: 29351228 Free PMC article.

2

The Microenvironment in Epstein-Barr Virus-Associated Malignancies.

Tan GW, Visser L, Tan LP, van den Berg A, Diepstra A. Tan GW, et al. Among authors: visser l. Pathogens. 2018 Apr 13;7(2):40. doi: 10.3390/pathogens7020040. Pathogens. 2018. PMID: 29652813 Free PMC article. Review.

3

Genetic Modification Approaches for Parasporins Bacillus thuringiensis Proteins with Anticancer Activity.

Suárez-Barrera MO, Visser L, Rondón-Villarreal P, Herrera-Pineda DF, Alarcón-Aldana JS, Van den Berg A, Orozco J, Pinzón-Reyes EH, Moreno E, Rueda-Forero NJ. Suárez-Barrera MO, et al. Among authors: visser l. Molecules. 2021 Dec 10;26(24):7476. doi: 10.3390/molecules26247476. Molecules. 2021. PMID: 34946558 Free PMC article. Review.

4

Primary and acquired resistance mechanisms to immune checkpoint inhibition in Hodgkin lymphoma.

Veldman J, Visser L, Berg AVD, Diepstra A. Veldman J, et al. Among authors: visser l. Cancer Treat Rev. 2020 Jan;82:101931. doi: 10.1016/j.ctrv.2019.101931. Epub 2019 Nov 11. Cancer Treat Rev. 2020. PMID: 31756590 Free article. Review.

5

Toll-like receptors in the pathogenesis of human B cell malignancies.

Isaza-Correa JM, Liang Z, van den Berg A, Diepstra A, Visser L. Isaza-Correa JM, et al. Among authors: visser l. J Hematol Oncol. 2014 Aug 12;7:57. doi: 10.1186/s13045-014-0057-5. J Hematol Oncol. 2014. PMID: 25112836 Free PMC article. Review.

6

Plasma cells in classical Hodgkin lymphoma: a new player in the microenvironment?

Visser L. Visser L. Br J Haematol. 2019 Jan;184(2):119-120. doi: 10.1111/bjh.15704. Epub 2018 Nov 28. Br J Haematol. 2019. PMID: 30485402 Free PMC article. No abstract available.

7

The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component.

Liu Y, Sattarzadeh A, Diepstra A, Visser L, van den Berg A. Liu Y, et al. Among authors: visser l. Semin Cancer Biol. 2014 Feb;24:15-22. doi: 10.1016/j.semcancer.2013.07.002. Epub 2013 Jul 15. Semin Cancer Biol. 2014. PMID: 23867303 Review.

8

Soluble PD-L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma.

Veldman J, Alsada ZND, van den Berg A, Plattel WJ, Diepstra A, Visser L. Veldman J, et al. Among authors: visser l. Br J Haematol. 2021 May;193(3):506-514. doi: 10.1111/bjh.17362. Epub 2021 Feb 23. Br J Haematol. 2021. PMID: 33620088 Free PMC article. Clinical Trial.

9

Genetic associations in classical hodgkin lymphoma: a systematic review and insights into susceptibility mechanisms.

Kushekhar K, van den Berg A, Nolte I, Hepkema B, Visser L, Diepstra A. Kushekhar K, et al. Among authors: visser l. Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2737-47. doi: 10.1158/1055-9965.EPI-14-0683. Epub 2014 Sep 9. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 25205514 Review.

10

Interaction between ERAP Alleles and HLA Class I Types Support a Role of Antigen Presentation in Hodgkin Lymphoma Development.

Jiang P, Veenstra RN, Seitz A, Nolte IM, Hepkema BG, Visser L, van den Berg A, Diepstra A. Jiang P, et al. Among authors: visser l. Cancers (Basel). 2021 Jan 22;13(3):414. doi: 10.3390/cancers13030414. Cancers (Basel). 2021. PMID: 33499248 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results